A complete
value chain
management
To enable
access to global,
advanced and
latest therapeutics
For the
patients-in-need
in rare and ultra-rare
diseases
Across Türkiye,
Europe and
Middle East
To develop innovative approaches that accelerate and facilitate access to both diagnosis and up-to-date treatment options for rare diseases through accurate and reliable collaborations.
To be a sought-after partner and leading service provider within the geographical region where we serve that facilitates patients access to diagnosis and treatment in the field of rare diseases with innovative, fast and effective business approaches within operating regions.
30 Ağustos Street, Mila Marina Residence No: 15, Office: 10
Kyrenia/TRNC
Hasan Kopar has worked as Sales Manager in leading companies in the field of Molecular Genetics for more than 20 years, and has been continuing his professional business life as a Shareholder of Labgen Laboratory Systems Group of Companies since 2011.
Özgür Basmacı has worked as General Manager and Founding Partner in leading companies in the sector for more than 30 years, and has been continuing his professional business life as the Founding Partner of Labgen Laboratory Systems Group of Companies since 2011.
He has successfully carried out large-scale laboratory services as the Distributor of companies with the most innovative product portfolio in their fields, such as Becton Dickinson, Roche Diagnostics, Beckman Coulter, Qiagen, in all regions where he is authorized.
He continues to bring his business stakeholders together with new technologies and products and to take his service quality one step further than, especially in the field of Molecular Genetics in public hospitals and the studies in research centers.
Hüseyin Sertaç Yalçınkaya, after completing his education in Chemistry, has made significant contributions to the Diagnostic sector by shaping his career as Sales-Marketing and Operations Management in the field of in Vitro Diagnostics. After a 14-year career at Siemens Healthineers.
He is currently working as the General Manager of Gensutek Companies. With the experience he has gained in the companies where he has worked, he has had deep knowledge and experience in the fields of in Vitro Diagnostics and Molecular Biology.
He is focused on Genetic Analysis, DNA/RNA Technologies, IVD Laboratory Solutions and Laboratory Automation Systems, and has signedmany successful projects in these areas.
Hüseyin Onay is Professor Doctor of Medical Genetics.
He is Owner and the Founder of Multigen Biotech Company.
Multigen produces Molecular Diagnostic Kits for both Sanger Sequencing and NGS Based Systems.
He is also Co-Owner and Co-Founder of Gene2Info which provides an end-to-end innovative solutions form global Pharmaceutical companies to Genetic Disorder Screening that will enable a significant increase in the number of diagnoses and improve the lives of patients with rare diseases.
Gene2Info is one of the leading companies in the world for family Screening Solutions.
Hüseyin Onay is Global KOL for Global Rare Disease Pharmaceutical Companies.
Prof. Dr. Tahir Atik, graduated from Ege University Faculty of Medicine in 1999, completed his Specialty Training at the Department of Pediatrics of the same university in 2004 and his Doctorate in Genetics in 2016.
He has been working as a Faculty Member at Ege University Faculty of Medicine, Department of Pediatric Genetics since 2012, and has been involved in numerous scientific publications, research projects and academic studies at national and international levels on the genetic basis of rare diseases.
Known for his clinical experience, academic knowledge and multidisciplinary research-oriented approach in the field of Pediatric Genetics.
Gülin Dönmez is an established leader in healthcare with a focus on biopharmaceuticals, rare diseases, genetics disorders and orphan drugs.
She holds a BSc Degree in Molecular Biology and Genetics from Boğaziçi Üniversity and also completed her Executive MBA Degree at Koc University.
She has more than 20 years of expertise evolved from mass into niche and orphan sphere across different functions and skills:
Market preparation and commercialization of orphan treatments,
Market access and reimbursement initiatives,
Affiliate start-ups, new product launches,
Analysis and research in patient journey,
Co-marketing and co-promotion experiences with a cross-cultural focus,
Sales force deployment,
SF and commercial excellence initiatives,
Performance management and talent management programs,
Business development,
Partnering feasibility research,
Business intelligence and MIS platforms,
Patient association management,
Sectoral NGOs.
She is passionate about working for rare diseases to add and create value for the patients, healthcare professionals and stakeholders of the disease community.